A new study sought to better define real-world initiation, management, and outcomes of patients with chronic lymphocytic leukemia treated with a standard-of-care therapy.
A recent study sought to determine the factors associated with durable remission after a complete response to CD19-targeting chimeric antigen receptor T-cell therapy in adult patients with B-cell acute lymphoblastic leukemia.
A systematic review of value-based health care delivery models in oncology care found that reports of outcomes are often lacking and show varying degrees of quality improvement.
Rates of survival have increased in patients with stage III to IV Hodgkin lymphoma over 3 decades as a result of improvements in the United States health care system.
A new real-world study compared the health care resource utilization and costs between patients treated for multiple myeloma with and without renal impairment.
An economic model comparing different types of genetic testing in metastatic non-small cell lung cancer showed that next-generation sequencing is more cost-effective than testing for one or a limited number of genes at a given time.
The National Comprehensive Cancer Network has released a free resource to help patients with acute myeloid leukemia and their families become better informed in treatment decision-making.
Four risk prediction models have been shown to accurately select the highest risk smokers for lung cancer screening.
A new study found that timely reporting of palliative care needs may lead to less aggressive therapy and end-of-life care among patients with non-small cell lung cancer.
A recent study identified four recurring themes related to organizational barriers to quality lung cancer care in a community hospital setting.